Department of Food and Nutrition, Gyeongsang National University, Jinju 52828, Republic of Korea.
Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, Henan, P.R. China.
J Microbiol Biotechnol. 2023 Dec 28;33(12):1552-1562. doi: 10.4014/jmb.2308.08016. Epub 2023 Aug 28.
Soybean () is an important ingredient of cuisines worldwide. While there is a wealth of evidence that soybean could be a good source of macronutrients and phytochemicals with health-promoting effects, concerns regarding adverse effects have been raised. In this work, we reviewed the current clinical evidence focusing on the benefits and risks of soybean ingredients. In breast, prostate, colorectal, ovarian, and lung cancer, epidemiological studies showed an inverse association between soybean food intake and cancer risks. Soybean intake was inversely correlated with risks of type 2 diabetes mellitus (T2DM), and soy isoflavones ameliorated osteoporosis and hot flashes. Notably, soybean was one of the dietary protein sources that may reduce the risk of breast cancer and T2DM. However, soybean had adverse effects on certain types of drug treatment and caused allergies. In sum, this work provides useful considerations for planning clinical soybean research and selecting dietary protein sources for human health.
大豆是全球饮食中一种重要的食材。尽管有大量证据表明,大豆是一种富含大量营养素和具有促进健康作用的植物化学物质的良好来源,但也有人担心其存在不良反应。在这项工作中,我们综述了目前关于大豆成分的益处和风险的临床证据。在乳腺癌、前列腺癌、结直肠癌、卵巢癌和肺癌中,流行病学研究表明,大豆食物的摄入与癌症风险呈负相关。大豆的摄入与 2 型糖尿病(T2DM)的风险呈负相关,大豆异黄酮可改善骨质疏松症和热潮红。值得注意的是,大豆是可能降低乳腺癌和 T2DM 风险的膳食蛋白质来源之一。然而,大豆对某些类型的药物治疗有不良影响,并会引起过敏。总之,这项工作为规划临床大豆研究和选择有益于人类健康的膳食蛋白质来源提供了有用的参考。